Amundi
ABCL icon

Amundi’s AbCellera Biologics ABCL Stock Holding History

Amundi’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26,567
Closed -$113K – 1999
2023
Q3 		$113K Hold
26,567
– – ﹤0.01% 1731
2023
Q2 		$175K Hold
26,567
– – ﹤0.01% 1637
2023
Q1 		$190K Buy
26,567
+9,790
+58% +$88.9K ﹤0.01% 1583
2022
Q4 		$161K Sell
16,777
-7,100
-30% -$82K ﹤0.01% 1543
2022
Q3 		$268K Hold
23,877
– – ﹤0.01% 1421
2022
Q2 		$265K Buy
+23,877
New +$202K ﹤0.01% 1334

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.7B AUM 22.47% 1-Year Est. Return